1. Comprehensive Analysis of Transcriptomic Profiles Identified the Prediction of Prognosis and Drug Sensitivity of Aminopeptidase-Like 1 (NPEPL1) for Clear Cell Renal Cell Carcinoma
   Xiaoyu Wei et al, 2023, Journal of Oncology CrossRef
2. Inhibition of Ras protein activator like 2 produces antitumor effects in gastric cancer via the suppression of YAP1 activation
   Yuan Hu et al, 2022, Environmental Toxicology CrossRef
3. RAS protein activator-like 2 (RASAL2) initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis
   Yu Zhang et al, 2024, Translational Research CrossRef
4. A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
   Qiqing Yang et al, 2023, Advanced Science CrossRef
5. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway
   Wei Li et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef